Skip to content

Carotid Ultrasound in the Evaluation of Heart Failure

Carotid Ultrasound in the Evaluation of Heart Failure

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00810550
Acronym
CUE-HF
Enrollment
150
Registered
2008-12-18
Start date
2005-10-31
Completion date
2008-12-31
Last updated
2016-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease, Cardiomyopathy, Heart Failure

Brief summary

Coronary artery disease (CAD, cholesterol plaque buildup in the heart arteries) is the most common cause of left ventricular systolic dysfunction (weakening of the heart muscle). The standard test to find coronary artery disease is coronary angiography. This test is highly accurate but is invasive and carries a small risk of complications. This study investigates ultrasound of the carotid (neck) arteries as a screening test for severe coronary artery disease as a cause of left ventricular systolic dysfunction. It is hypothesized that carotid ultrasound will have excellent negative predictive value for severe CAD.

Detailed description

Coronary artery disease (CAD, cholesterol plaque buildup in the heart arteries) is the most common cause of left ventricular systolic dysfunction (weakening of the heart muscle). The standard test to find coronary artery disease is coronary angiography. This test is highly accurate but is invasive and carries a small risk of complications. This study investigates ultrasound of the carotid (neck) arteries as a screening test for severe coronary artery disease as a cause of left ventricular systolic dysfunction. It is hypothesized that carotid ultrasound will have excellent negative predictive value for severe CAD.

Interventions

Measurement of intima-media thickness

Sponsors

NYU Langone Health
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* LVEF 40% or less

Exclusion criteria

* Prior diagnosis of coronary or carotid obstructive atherosclerosis

Design outcomes

Primary

MeasureTime frame
Diagnostic accuracy for severe CAD1 Day

Secondary

MeasureTime frame
Diagnostic accuracy for significant CAD1 Day

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026